Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years

Abroad (travel likely)Recruiting

Conditions

Heart Failure · Primary Prevention of Sudden Cardiac Death · Implantable Cardioverter Defibrillator

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Eloi MARIJON, MD, PhD

    Principal Investigator

    AP-HP, Hôpital européen Georges Pompidou, Paris

  • Rodrigue GARCIA, MD, PhD

    Study Director

    CHU Poitiers, France